PFS Cancer Research Results
PFS, progression-free survival: Click to Expand ⟱
| Source: |
| Type: |
| PFS (progression-free survival) is the time from a defined starting point—usually randomization or treatment initiation—until documented disease progression or death, whichever occurs first
|
Scientific Papers found: Click to Expand⟱
DCR↑, OS∅, PFS∅, ORR∅, AEs∅, QoL∅,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
*BioAv↝, *cardioP↑, *Obesity↓, *neuroP↑, *toxicity↝, *Dose↝, *GutMicro↑, *AMPK↑, *glucose↓, *NLRP3↑, *Inflam↓, *Stroke↓, *Cartilage↑, FOXP3↑, TumAuto↑, mTOR↓, PD-L1↓, RadioS↑, ChemoSen↑, ROS↓, OXPHOS↓, compI↓, Glycolysis↝, TumCP↓, *BioAv↝, *AntiAge↑, *SIRT1↑, *cognitive↑, *Risk↓, Ki-67↓, Synergy↝, PFS∅, OS∅,
Showing Research Papers: 1 to 2 of 2
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 2
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
ROS↓, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
compI↓, 1, OXPHOS↓, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
Glycolysis↝, 1,
Kinase & Signal Transduction(tgid=6) ⓘ
mTOR↓, 1,
Autophagy & Lysosomes(tgid=9) ⓘ
TumAuto↑, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
Ki-67↓, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
Ki-67↓, 1, TumCP↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
FOXP3↑, 1, PD-L1↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
ChemoSen↑, 1, RadioS↑, 1, Synergy↝, 1,
Clinical Biomarkers(tgid=22) ⓘ
PD-L1↓, 1,
Functional Outcomes(tgid=23) ⓘ
AEs∅, 1, DCR↑, 1, ORR∅, 1, OS∅, 2, PFS∅, 2, QoL∅, 1,
Total Targets: 21
Pathway results for Effect on Normal Cells:
Core Metabolism/Glycolysis(tgid=4) ⓘ
AMPK↑, 1, glucose↓, 1, SIRT1↑, 1,
Migration(tgid=13) ⓘ
Cartilage↑, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
Inflam↓, 1, NLRP3↑, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↝, 2, Dose↝, 1,
Functional Outcomes(tgid=23) ⓘ
AntiAge↑, 1, cardioP↑, 1, cognitive↑, 1, neuroP↑, 1, Obesity↓, 1, Risk↓, 1, Stroke↓, 1, toxicity↝, 1,
Infection & Microbiome(tgid=24) ⓘ
GutMicro↑, 1,
Total Targets: 17
Scientific Paper Hit Count for: PFS, progression-free survival
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:0 prod#:% Target#:1559 State#:% Dir#:6
wNotes=0 sortOrder:rid,rpid
Home Page